Clinical Trial Update: ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of ASP1517 in anemia patients on hemodialysis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• ASP1517

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Anemia, Hemodialysis | Phase 1 | Status: COMPLETED